Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1300, 2001-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lamivudine plus IFN- -2b: potential in hepatitis B?
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :
Severe Depression: Is There a Best Approach?
CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. :
PEG IFN- -2b + ribavirin: 24 weeks sufficient for HCV-2 and HCV-3?
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
High-dose IFN- -2b improves survival in melanoma?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Contraindication for BCG + IFN-α-2b in pacemakers warranted?
Reactions Weekly, Vol. 1, Iss. 1295-1296, 2010-01 ,pp. :